Literature DB >> 22445965

Filovirus entry into cells - new insights.

Emily Happy Miller1, Kartik Chandran.   

Abstract

Filoviruses are hemorrhagic fever-causing agents that produce enveloped virions with a filamentous morphology. The viral surface glycoprotein, GP, orchestrates the surprisingly complex process by which filoviruses gain access to the cytoplasm of their host cells. GP mediates viral attachment to cells through multiple, redundant interactions with cell-surface factors. GP then induces virion internalization by a process that resembles cellular macropinocytosis. Within the endo/lysosomal pathway, GP undergoes a series of structural rearrangements, controlled by interactions with host factors, that prime and activate it to bring about fusion between the viral and cellular lipid bilayers. Membrane fusion delivers the viral nucleocapsid core into the cytoplasm, which is the site of filovirus replication. This review summarizes our understanding of the filovirus entry mechanism, with emphasis on recent findings.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22445965      PMCID: PMC3322298          DOI: 10.1016/j.coviro.2012.02.015

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  61 in total

1.  Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry.

Authors:  Derek Dube; Kathryn L Schornberg; Charles J Shoemaker; Sue E Delos; Tzanko S Stantchev; Kathleen A Clouse; Christopher C Broder; Judith M White
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-03       Impact factor: 11.205

2.  Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor.

Authors:  Jens H Kuhn; Sheli R Radoshitzky; Alexander C Guth; Kelly L Warfield; Wenhui Li; Martin J Vincent; Jonathan S Towner; Stuart T Nichol; Sina Bavari; Hyeryun Choe; M Javad Aman; Michael Farzan
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

3.  A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry.

Authors:  Anthony C Wong; Rohini G Sandesara; Nirupama Mulherkar; Sean P Whelan; Kartik Chandran
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

4.  Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain.

Authors:  W Weissenhorn; A Carfí; K H Lee; J J Skehel; D C Wiley
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

5.  Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change.

Authors:  Matthew Brecher; Kathryn L Schornberg; Sue E Delos; Marnie L Fusco; Erica Ollmann Saphire; Judith M White
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

6.  Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.

Authors:  Kartik Chandran; Nancy J Sullivan; Ute Felbor; Sean P Whelan; James M Cunningham
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

7.  T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus.

Authors:  Andrew S Kondratowicz; Nicholas J Lennemann; Patrick L Sinn; Robert A Davey; Catherine L Hunt; Sven Moller-Tank; David K Meyerholz; Paul Rennert; Robert F Mullins; Melinda Brindley; Lindsay M Sandersfeld; Kathrina Quinn; Melodie Weller; Paul B McCray; John Chiorini; Wendy Maury
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

8.  Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution.

Authors:  V N Malashkevich; B J Schneider; M L McNally; M A Milhollen; J X Pang; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

9.  Tyro3 family-mediated cell entry of Ebola and Marburg viruses.

Authors:  Masayuki Shimojima; Ayato Takada; Hideki Ebihara; Gabriele Neumann; Kouki Fujioka; Tatsuro Irimura; Steven Jones; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

10.  Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR.

Authors:  George Lin; Graham Simmons; Stefan Pöhlmann; Frédéric Baribaud; Houping Ni; George J Leslie; Beth S Haggarty; Paul Bates; Drew Weissman; James A Hoxie; Robert W Doms
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  41 in total

1.  Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity.

Authors:  Gopi S Mohan; Ling Ye; Wenfang Li; Ana Monteiro; Xiaoqian Lin; Bishu Sapkota; Brian P Pollack; Richard W Compans; Chinglai Yang
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Ebolavirus Glycoprotein Directs Fusion through NPC1+ Endolysosomes.

Authors:  James A Simmons; Ryan S D'Souza; Margarida Ruas; Antony Galione; James E Casanova; Judith M White
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

3.  The transition from a rural to an urban environment alters expression of the human Ebola virus receptor Neiman-Pick C1: implications for the current epidemic in West Africa.

Authors:  Stephen W Bickler; Radhames E Lizardo; Antonio De Maio
Journal:  Cell Stress Chaperones       Date:  2014-12-05       Impact factor: 3.667

4.  Structural and Functional Studies on the Marburg Virus GP2 Fusion Loop.

Authors:  Nina Liu; Yisong Tao; Michael D Brenowitz; Mark E Girvin; Jonathan R Lai
Journal:  J Infect Dis       Date:  2015-03-18       Impact factor: 5.226

5.  Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses.

Authors:  Anna Z Wec; Andrew S Herbert; Charles D Murin; Elisabeth K Nyakatura; Dafna M Abelson; J Maximilian Fels; Shihua He; Rebekah M James; Marc-Antoine de La Vega; Wenjun Zhu; Russell R Bakken; Eileen Goodwin; Hannah L Turner; Rohit K Jangra; Larry Zeitlin; Xiangguo Qiu; Jonathan R Lai; Laura M Walker; Andrew B Ward; John M Dye; Kartik Chandran; Zachary A Bornholdt
Journal:  Cell       Date:  2017-05-18       Impact factor: 41.582

6.  Conformational properties of peptides corresponding to the ebolavirus GP2 membrane-proximal external region in the presence of micelle-forming surfactants and lipids.

Authors:  Lauren K Regula; Richard Harris; Fang Wang; Chelsea D Higgins; Jayne F Koellhoffer; Yue Zhao; Kartik Chandran; Jianmin Gao; Mark E Girvin; Jonathan R Lai
Journal:  Biochemistry       Date:  2013-05-07       Impact factor: 3.162

7.  Ebolavirus entry requires a compact hydrophobic fist at the tip of the fusion loop.

Authors:  Sonia M Gregory; Per Larsson; Elizabeth A Nelson; Peter M Kasson; Judith M White; Lukas K Tamm
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

8.  Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1.

Authors:  Melinda Ng; Esther Ndungo; Rohit K Jangra; Yingyun Cai; Elena Postnikova; Sheli R Radoshitzky; John M Dye; Eva Ramírez de Arellano; Ana Negredo; Gustavo Palacios; Jens H Kuhn; Kartik Chandran
Journal:  Virology       Date:  2014-10-11       Impact factor: 3.616

9.  Therapeutics for postexposure treatment of Ebola virus infection.

Authors:  Marina Jerebtsova; Sergei Nekhai
Journal:  Future Virol       Date:  2015-03       Impact factor: 1.831

10.  C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking.

Authors:  Chelsea D Higgins; Jayne F Koellhoffer; Kartik Chandran; Jonathan R Lai
Journal:  Bioorg Med Chem Lett       Date:  2013-08-02       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.